The health industry is one of the most important components of the United States economy – and demographic trends show that this industry will continue to grow in significance. With this growth will come an increase in regulations, scrutiny and influence by federal, state and local governments. The Livingston Group healthcare and pharmaceuticals team is prepared to assist.
Our team has helped clients win major healthcare policy and reform debates, appropriated funds and favorable outcomes from federal agencies and secured federal funding for our clients’ initiatives.
Our government affairs and health industry specialists have a wide breadth of experience and strong relationships with numerous members of the US Congress, including the leadership of both political parties and congressional staff. Several members of our team enjoy long-term working relationships with key individuals throughout the federal health system, including the Department of Health and Human Services (HHS), The Centers for Medicare and Medicaid Services (CMS), the Health Resources and Services Administration (HRSA), the Food and Drug Administration (FDA), the Centers for Disease Control (CDC), and the National Institutes of Health (NIH). Members of our team also have close, long-term relationships with White House, presidential, and executive branch staff.
Since each sector of the healthcare industry has its own unique rules and standards for operation, we believe industry knowledge is an essential tool in our representation. We also offer extensive private healthcare business experience in our representation, as our team includes former CEOs, presidents, directors and senior vice presidents from the pharmaceutical, health insurance, medical professional, medical device and technology fields, in addition to academic research and healthcare association advocacy specialties.
The Livingston Group will ensure that your viewpoints are heard consistently and dealt with rationally in the intertwined world of government programs.